Current guidelines recommend dual antiplatelet therapy, a combination of aspirin and a P2Y 12 inhibitor, for 6–12 months after percutaneous coronary intervention with drug-eluting stent implantation ...
Combining an antiplatelet with oral anticoagulants in stroke patients with AF and cardiovascular disease slightly lowers ...
Bentracimab effectively reversed ticagrelor's antiplatelet effects, restoring platelet function in minutes for most patients in urgent situations. The REVERSE-IT trial showed 94.3% of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback